InflaRx (IFRX) Selling, General & Administrative (2016 - 2026)
InflaRx (IFRX) Selling, General & Administrative (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
SG&A (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
17.02 Mn |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
1.32 Mn |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
-37.00 Mn |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
2.17 Mn |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
-1.52 Mn |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
217,225.00 |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
493.70 Mn |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
-7.36 Mn |
| 10 |
InflaRx |
764.68 Mn |
764.68 Mn |
10,877.40 |
-3.72 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-3.72 Mn |
| Dec 31, 2025 |
12.78 Mn |
| Sep 30, 2025 |
-3.06 Mn |
| Jun 30, 2025 |
-3.71 Mn |
| Mar 31, 2025 |
-5.33 Mn |
| Dec 31, 2024 |
24.19 Mn |
| Sep 30, 2024 |
-3.08 Mn |
| Jun 30, 2024 |
-3.47 Mn |
| Mar 31, 2024 |
-3.89 Mn |
| Dec 31, 2023 |
10.91 Mn |
| Sep 30, 2023 |
-3.15 Mn |
| Jun 30, 2023 |
-3.86 Mn |
| Mar 31, 2023 |
-3,873.21 Bn |
| Dec 31, 2022 |
-3.11 Mn |
| Sep 30, 2022 |
-3,112.83 Bn |
| Jun 30, 2022 |
-4.64 Mn |
| Mar 31, 2022 |
-4.92 Mn |
| Dec 31, 2021 |
-13,710.16 Bn |
| Sep 30, 2021 |
-4.00 Mn |
| Jun 30, 2021 |
-3.25 Mn |
